{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:47:03Z","timestamp":1751960823705},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clinre.2024.102403","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:16:38Z","timestamp":1718781398000},"page":"102403","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression"],"prefix":"10.1016","volume":"48","author":[{"given":"Wei","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2024.102403_bib0001","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2024.102403_bib0002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J Engl"},{"issue":"10360","key":"10.1016\/j.clinre.2024.102403_bib0003","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clinre.2024.102403_bib0004","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.clinre.2024.102403_bib0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3350\/cmh.2023.0106","article-title":"Management of hepatocellular carcinoma in China: seeking common grounds while reserving differences","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"10381","key":"10.1016\/j.clinre.2024.102403_bib0006","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clinre.2024.102403_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular CARCINOMA: new developments","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2024.102403_bib0008","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1186\/s12885-021-08904-3","article-title":"Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database","volume":"21","author":"Ding","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clinre.2024.102403_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.clinre.2024.102403_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106674","article-title":"Biomarker discovery and application-an opportunity to resolve the challenge of liver cancer diagnosis and treatment","volume":"189","author":"Chen","year":"2023","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1016\/j.clinre.2024.102403_bib0011","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41568-023-00602-5","article-title":"Cancers make their own luck: theories of cancer origins","volume":"23","author":"Jassim","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clinre.2024.102403_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.959852","article-title":"Racial disparities in liver cancer: evidence for a role of environmental contaminants and the epigenome","volume":"12","author":"Vidal","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clinre.2024.102403_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111224","article-title":"LncRNA influence sequential steps of hepatocellular carcinoma metastasis","volume":"136","author":"Lv","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.clinre.2024.102403_bib0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s10020-021-00278-3","article-title":"LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Mol Med"},{"key":"10.1016\/j.clinre.2024.102403_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2018.05.010","article-title":"LncRNA n335586\/miR-924\/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells","volume":"429","author":"Fan","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2024.102403_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9972011","article-title":"Potential lncRNA biomarkers for HBV-related hepatocellular carcinoma diagnosis revealed by analysis on coexpression network","volume":"2021","author":"Nong","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clinre.2024.102403_bib0017","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-023-00995-6","article-title":"LINC02532 by mediating miR-541-3p\/HMGA1 axis exerts a tumor promoter in breast cancer","author":"Zhao","year":"2023","journal-title":"Mol Biotechnol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102403_bib0018","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4251\/wjgo.v11.i2.91","article-title":"Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro","volume":"11","author":"Zhang","year":"2019","journal-title":"World J Gastrointest Oncol"},{"issue":"22","key":"10.1016\/j.clinre.2024.102403_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26227040","article-title":"LINC02532 contributes to radiosensitivity in clear cell renal cell carcinoma through the miR-654-5p\/YY1 axis","volume":"26","author":"Zhou","year":"2021","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.clinre.2024.102403_bib0020","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2174\/1568026617666161116144744","article-title":"LncRNA as a therapeutic target for angiogenesis","volume":"17","author":"Kumar","year":"2017","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.clinre.2024.102403_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","article-title":"Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma","volume":"342","author":"Pogribny","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2024.102403_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834650","article-title":"Diversity of dysregulated long non-coding RNAs in HBV-related hepatocellular carcinoma","volume":"13","author":"Samudh","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102403_bib0023","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3748\/wjg.v20.i5.1268","article-title":"Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials","volume":"20","author":"Scaggiante","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102403_bib0024","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The mechanisms of HBV-induced hepatocellular carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.clinre.2024.102403_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/473942","article-title":"Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs","volume":"2015","author":"Amicone","year":"2015","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.clinre.2024.102403_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092622","article-title":"Epigenetic associations between lncRNA\/circRNA and miRNA in hepatocellular carcinoma","volume":"12","author":"Han","year":"2020","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.clinre.2024.102403_bib0027","doi-asserted-by":"crossref","first-page":"e21700","DOI":"10.1096\/fj.202002319RRR","article-title":"The miR-455-3p\/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics","volume":"35","author":"You","year":"2021","journal-title":"Faseb J"},{"key":"10.1016\/j.clinre.2024.102403_bib0028","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2019.05.001","article-title":"miR-455-3p alleviates hepatic stellate cell activation and liver fibrosis by suppressing HSF1 expression","volume":"16","author":"Wei","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10.1016\/j.clinre.2024.102403_bib0029","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/tox.23516","article-title":"MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma","volume":"37","author":"Ma","year":"2022","journal-title":"Environ Toxicol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102403_bib0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gutjnl-2016-313114","article-title":"CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression","volume":"67","author":"Carloni","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.clinre.2024.102403_bib0031","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1099\/vir.0.000150","article-title":"Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression","volume":"96","author":"Kim","year":"2015","journal-title":"J Gen Virol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:13:58Z","timestamp":1723011238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2210740124001244"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102403","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102403"}}